Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension
作者： Dan Henrohn , Anna Sandqvist , Hanna Egeröd , Mikael Hedeland , Lisa Wernroth
DOI: 10.1016/J.VPH.2015.04.010
关键词: Asymmetric dimethylarginine 、 Pulmonary hypertension 、 In patient 、 Arginine 、 Chemistry 、 Pharmacology 、 Plasma levels 、 Vardenafil 、 Symmetric dimethylarginine 、 Hemodynamics
摘要: OBJECTIVE: We investigated whether vardenafil, a phosphodiesterase-5 inhibitor, alters plasma levels of asymmetric dimethylarginine (ADMA), symmetric (SDMA), and arginine.PATIENTS ...
sci-hub.se 参考文章(46)
Dan Henrohn, Anna Sandqvist, Mikael Hedeland, Hanna Egeröd, Ulf Bondesson, Gerhard Wikström, Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension. British Journal of Clinical Pharmacology. ,vol. 74, pp. 990- 998 ,(2012) , 10.1111/J.1365-2125.2012.04303.X
Zhi-Cheng Jing, Zai-Xin Yu, Jie-Yan Shen, Bing-Xiang Wu, Kai-Feng Xu, Xian-Yang Zhu, Lei Pan, Zhuo-Li Zhang, Xue-Qin Liu, Yu-Shun Zhang, Xin Jiang, Nazzareno Galiè, None, Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 1723- 1729 ,(2011) , 10.1164/RCCM.201101-0093OC
Sanjay Mehta, Duncan J. Stewart, David Langleben, Robert D. Levy, Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension Circulation. ,vol. 92, pp. 1539- 1545 ,(1995) , 10.1161/01.CIR.92.6.1539
Zhen-fei Fang, Yi-yuan Huang, Liang Tang, Xin-qun Hu, Xiang-qian Shen, Jian-jun Tang, Sheng-hua Zhou, None, Asymmetric Dimethyl-l-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease Pediatric Cardiology. ,vol. 36, pp. 1062- 1069 ,(2015) , 10.1007/S00246-015-1127-3
Gregory J. Kato, Zeneng Wang, Roberto F. Machado, William C. Blackwelder, James G. Taylor th, Stanley L. Hazen, Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology. ,vol. 145, pp. 506- 513 ,(2009) , 10.1111/J.1365-2141.2009.07658.X
Cleber E. Teixeira, Fernanda B. M. Priviero, R. Clinton Webb, Differential Effects of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Vardenafil, and Tadalafil in Rat Aorta Journal of Pharmacology and Experimental Therapeutics. ,vol. 316, pp. 654- 661 ,(2006) , 10.1124/JPET.105.092544
Arthur J. Pope, Kanchana Karuppiah, Arturo J. Cardounel, Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide production Pharmacological Research. ,vol. 60, pp. 461- 465 ,(2009) , 10.1016/J.PHRS.2009.07.016
Ellen I. Closs, Fatima Z. Basha, Alice Habermeier, Ulrich Förstermann, Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B Nitric Oxide. ,vol. 1, pp. 65- 73 ,(1997) , 10.1006/NIOX.1996.0106
Clifford L. Cua, Lynette K. Rogers, Louis G. Chicoine, Molly Augustine, Yi Jin, Patricia L. Nash, Leif D. Nelin, Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine. European Journal of Pediatrics. ,vol. 170, pp. 859- 863 ,(2011) , 10.1007/S00431-010-1361-X
Kazunori AIZAWA, Takeshi HANAOKA, Hiroki KASAI, Kaoru KOGASHI, Setsuo KUMAZAKI, Jun KOYAMA, Hiroshi TSUTSUI, Yoshikazu YAZAKI, Noboru WATANABE, Osamu KINOSHITA, Uichi IKEDA, Long-Term Vardenafil Therapy Improves Hemodynamics in Patients with Pulmonary Hypertension Hypertension Research. ,vol. 29, pp. 123- 128 ,(2006) , 10.1291/HYPRES.29.123